Medicine News and Research

RSS

Symptom screening plus CA125 blood test improves early detection of ovarian cancer

Women's reports of persistent, recent-onset symptoms linked to ovarian cancer - abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating - when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent, according to new findings by researchers at Fred Hutchinson Cancer Research Center published online today in CANCER.

24 Jun 2008

Drug rapamycin reverses mental retardation caused by tuberous sclerosis complex

UCLA researchers discovered that an FDA-approved drug reverses the brain dysfunction inflicted by a genetic disease called tuberous sclerosis complex (TSC). Because half of TSC patients also suffer from autism, the findings offer new hope for addressing learning disorders due to autism. Nature Medicine publishes the findings in its online June 22 edition.

23 Jun 2008

Lower blood levels of vitamin D linked to increased heart problems

Individuals with lower blood levels of vitamin D appear to have an increased risk of death overall and from cardiovascular causes, according to a report in the June 23 issue of Archives of Internal Medicine.

23 Jun 2008

Hedgehog signaling is critical for maintenance of the adult coronary vasculature

A set of promising new anticancer agents could have unforeseen risks in individuals with heart disease, suggests research at Washington University School of Medicine in St. Louis.

23 Jun 2008

New way to limit gene transfer and expression

Researchers from Northwestern University and Texas A & M University have discovered a new way to limit gene transfer and expression to specific tissues in animals.

23 Jun 2008

Management of hypertension immediately after stroke

A research project at the University of Leicester in conjunction with the University of East Anglia, indicates that early reduction of high blood pressure following stroke is feasible and safe, and both Labetalol & Lisinopril were found to be suitable a medications for this purpose.

23 Jun 2008

Could Gleevec help stroke victims?

For over a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke. But its promise is blemished by two facts: tPA can cause dangerous bleeding in the brain, and its brain-saving power fades fast after the third hour of a stroke.

23 Jun 2008

Study provides direct proof on how key protein promotes vascular disease

Researchers have found the first direct proof that a key protein drives the clogging of arteries in two ways, and that lowering levels of it opens them up, according to study results published in the June edition of the journal Circulation.

23 Jun 2008

New white wine as good for you as red!

Red wine is favoured by many health conscious tipplers because it contains higher levels of polyphenols - antioxidants which lower cholesterol and are thought to help prevent cancer.

23 Jun 2008

New method for bone tissue engineering wins award

A new and better method for accelerating bone formation in cases of orthopedic injuries and conditions, such as osteoporosis, fractures and disc disorders, has been developed by Nadav Kimelman at the Hebrew University of Jerusalem's Faculty of Dental Medicine.

23 Jun 2008

Dr Chris Mason appointed Senior Editor of Regenerative Medicine

The journal Regenerative Medicine has announced the promotion of Dr Chris Mason to Senior Editor. Dr Mason succeeds Dr Stephen Minger who has steered the journal since its launch in January 2006.

23 Jun 2008

Discovery of possible new way to block inflammation in autoimmune disease

Researchers from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH), have identified a promising new target for autoimmune disease treatment - a cell-surface receptor called DR3.

23 Jun 2008

Ranbaxy and Pfizer settle on Lipitor patent litigation

Ranbaxy Laboratories Limited (Ranbaxy), announced today that it has entered into an agreement with Pfizer Inc. to settle most of the patent litigation worldwide involving Atorvastatin (Lipitor), the world's most-prescribed cholesterol-lowering medicine.

19 Jun 2008

Patient's own infection-fighting T cells put late-stage melanoma into long-term remission

Researchers describe the first successful use of a human patient's cloned infection-fighting T cells as the sole therapy to put an advanced solid-tumor cancer into long-term remission. A team led by Cassian Yee, M.D., an associate member of the Clinical Research Division at Fred Hutchinson Cancer Research Center, reports these findings in the June 19 issue of the New England Journal of Medicine.

19 Jun 2008

Risk factors for sudden death for adult muscular dystrophy identified

The largest assessment of people with adult muscular dystrophy has identified risk factors that can lead to sudden death for individuals with the most common form of this disease.

19 Jun 2008

Discovery of potential key to better drugs to fight Toxoplasmosis parasite

Discoveries by IU School of Medicine scientists have opened a promising door to new drugs for toxoplasmosis and other parasites that now can evade treatments by turning dormant in the body.

19 Jun 2008

Why depression and diabetes often go together ...but which comes first?

While researchers have long been aware that type-2 diabetes and depression often go together, which develops first has always been unclear.

19 Jun 2008

Scientists cure advanced skin cancer with body's own cells

Scientists in the U.S. are claiming they have cured advanced skin cancer by using the patient's own cells.

19 Jun 2008

New AMA public health policies on vitamin D, processed foods, flavored cigarettes, tobacco sales, disaster medicine and seniors

The American Medical Association (AMA), the nation's largest physician organization, voted today at its Annual Meeting to adopt the following new public health policies.

17 Jun 2008

Kaiser Daily Health Policy Report rounds up health news from the campaign trail

Fifty-three percent of U.S. adults trust presumptive Democratic presidential nominee Sen. Barack Obama (Ill.) more than presumptive Republican nominee Sen. John McCain (Ariz.) to address the issue of health care, compared with 33% who trust McCain more than Obama to address the issue, according to a recent Washington Post-ABC News poll, the Post reports.

17 Jun 2008